Praxis Precision Medicines (PRAX) Accounts Payables (2022 - 2025)
Historic Accounts Payables for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $30.8 million.
- Praxis Precision Medicines' Accounts Payables rose 10532.31% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year increase of 10532.31%. This contributed to the annual value of $12.5 million for FY2024, which is 11544.28% up from last year.
- Latest data reveals that Praxis Precision Medicines reported Accounts Payables of $30.8 million as of Q3 2025, which was up 10532.31% from $28.8 million recorded in Q2 2025.
- Praxis Precision Medicines' Accounts Payables' 5-year high stood at $30.8 million during Q3 2025, with a 5-year trough of $5.8 million in Q4 2023.
- Moreover, its 4-year median value for Accounts Payables was $12.5 million (2024), whereas its average is $14.4 million.
- In the last 5 years, Praxis Precision Medicines' Accounts Payables tumbled by 6036.67% in 2023 and then soared by 25182.43% in 2025.
- Praxis Precision Medicines' Accounts Payables (Quarter) stood at $14.7 million in 2022, then crashed by 60.37% to $5.8 million in 2023, then soared by 115.44% to $12.5 million in 2024, then skyrocketed by 146.0% to $30.8 million in 2025.
- Its last three reported values are $30.8 million in Q3 2025, $28.8 million for Q2 2025, and $22.9 million during Q1 2025.